中国医学创新
中國醫學創新
중국의학창신
MEDICAL INNOVATION OF CHINA
2013年
35期
37-38
,共2页
胺碘酮%酒石酸美托洛尔%室性心律失常%疗效
胺碘酮%酒石痠美託洛爾%室性心律失常%療效
알전동%주석산미탁락이%실성심률실상%료효
Amiodarone%Metoprolol%Ventricular arrhythmias%Curative effects
目的:观察胺碘酮联合酒石酸美托洛尔治疗心律失常的疗效。方法:选择本院2010年3月-2013年3月收治的84例室性心律失常患者作为研究对象,随机均分为试验组和对照组,对照组在常规治疗的基础上单用酒石酸美托洛尔,试验组在常规治疗的基础上给予胺碘酮联合酒石酸美托洛尔治疗,比较两组患者的治疗效果。结果:试验组患者治疗总有效率显著高于对照组,差异具有统计学意义(P<0.05)。结论:胺碘酮联合酒石酸美托洛尔治疗室性心律失常疗效显著优于单用酒石酸美托洛尔,无严重不良反应,安全有效。
目的:觀察胺碘酮聯閤酒石痠美託洛爾治療心律失常的療效。方法:選擇本院2010年3月-2013年3月收治的84例室性心律失常患者作為研究對象,隨機均分為試驗組和對照組,對照組在常規治療的基礎上單用酒石痠美託洛爾,試驗組在常規治療的基礎上給予胺碘酮聯閤酒石痠美託洛爾治療,比較兩組患者的治療效果。結果:試驗組患者治療總有效率顯著高于對照組,差異具有統計學意義(P<0.05)。結論:胺碘酮聯閤酒石痠美託洛爾治療室性心律失常療效顯著優于單用酒石痠美託洛爾,無嚴重不良反應,安全有效。
목적:관찰알전동연합주석산미탁락이치료심률실상적료효。방법:선택본원2010년3월-2013년3월수치적84례실성심률실상환자작위연구대상,수궤균분위시험조화대조조,대조조재상규치료적기출상단용주석산미탁락이,시험조재상규치료적기출상급여알전동연합주석산미탁락이치료,비교량조환자적치료효과。결과:시험조환자치료총유효솔현저고우대조조,차이구유통계학의의(P<0.05)。결론:알전동연합주석산미탁락이치료실성심률실상료효현저우우단용주석산미탁락이,무엄중불량반응,안전유효。
Objective:To observe the curative effects of Adodarone combined with Metoprolol in treatment of ventricular arrhythmias.Method:84 cases of ventricular arrhythmias in our hospital from March 2010 to March 2013 were selected as the study objects and randomly divided into the experimental group and control group.The control group were added Metoprolol only on the basis of conventional treatment,and the experimental group were added Amiodarone combined with Metoprolol on the basis of conventional treatment.The course was 6 months.The curative effects of these two groups were compared.Result:The total effective rate of experimental group after the treatment was higher than that of the control group,the difference had statistical significance(P<0.05). Conclusion:The curative effect of Adodarone combined with Metoprolol in treatment of ventricular arrhythmias was significantly better than that of Metoprolol only,and there were no severe adverse reactions,which was safety and effective.